Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actinide ions refer to the cationic forms of the elements in the actinide series (atomic numbers 89–103, actinium through lawrencium), which are heavy, radioactive metals with partially filled 5f electron shells. Actinides frequently form multiple positive ions in solution (commonly +3, +4, +5, or +6 oxidation states) and have a strong tendency to form coordination complexes. These ions are highly electropositive and react readily with water, acids, and organic/inorganic ligands, and are distinguished by large ionic radii, high charge density, and strong radioactive decay. Their presence in the environment is of concern due to potent radiochemistry and toxicity. Unlike classic drug targets (such as receptors, enzymes, or transporters), actinide ions are not molecules with biological function in human physiology and are not recognized as therapeutic targets. Notes on data quality: - “Actinide ions” is not a canonical biological drug target, but a plural, generic chemical grouping of metal ions; it does not refer to a receptor, enzyme, or similar therapeutically actionable entity. - The entry is likely incorrect, overly generic, or missing sufficient specificity. For example, “Uranium ion” or “Plutonium ion” would more accurately specify a particular actinide in a defined oxidation state. - Actinide ions do not serve as endogenous molecular targets in therapeutics; rather, therapies and chelators are developed to bind and remove actinide ions in cases of poisoning, and they are of major interest in nuclear medicine, radiochemistry, and environmental health—but not in classic target-based drug discovery. Summary: “Actinide ion” is not a receptor, enzyme, transporter, or other standard molecular drug target. It refers collectively to the cations of radioactive actinide elements, which are notable for their radiological risk and chemical reactivity, but do not have canonical biological functions or typical roles in disease as molecular targets. Their main relevance is in the context of nuclear health and environmental toxicology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actinide ion.